School of Medicine


Showing 1-50 of 124 Results

  • Steven Adelsheim

    Steven Adelsheim

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioSteven Adelsheim, MD is a child/adolescent and adult psychiatrist who works to support community behavioral health partnerships locally, regionally, at the state level and nationally. He is the Director of the Stanford Center for Youth Mental Health and Wellbeing in the Department of Psychiatry. Dr. Adelsheim has partnered in developing statewide mental health policy and systems, including those focused on school mental health, telebehavioral health, tribal behavioral health programs, and suicide prevention. For many years Dr. Adelsheim has been developing and implementing early detection/intervention programs for young people in school-based and primary care settings, including programs for depression, anxiety, prodromal symptoms of psychosis, and first episodes of psychosis. Dr. Adelsheim is also involved in the implementation of integrated behavioral health care models in primary care settings as well as the use of media to decrease stigma surrounding mental health issues. He is currently leading the US effort to implement the headspace model of mental health early intervention for young people ages 12-25 based in Australia. Dr. Adelsheim also leads the national clinical network for early psychosis programs called PEPPNET.

  • Rania Awaad, MD

    Rania Awaad, MD

    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsAs the Director of the Muslims and Mental Health Lab, Dr. Awaad is dedicated to creating an academic home for the study of mental health as it relates to the Islamic faith and Muslim populations. The lab aims to provide the intellectual resources to clinicians, researchers, trainees, educators, community and religious leaders working with or studying Muslims.

  • Rebecca A. Bernert, PhD, ABPP, FT

    Rebecca A. Bernert, PhD, ABPP, FT

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioI am an Assistant Professor of Psychiatry and Behavioral Sciences and a licensed clinical psychologist in the Stanford University School of Medicine. I am a suicidologist, with subspecialty expertise in clinical trials, epidemiology, and suicide prevention best practices. I have joint specialty in behavioral sleep medicine, treatment development, and thanatology. I am Founding Director of The Stanford Suicide Prevention Research Laboratory, and Co-Chair a number of initiatives to support multidisciplinary efforts in suicide prevention. Our program utilizes cognitive, biological (e.g., fMRI), and behavioral testing paradigms, with an emphasis on translational therapeutics across the lifespan. Our mission is to identify novel therapeutics, including seminal work to establish the subfield of sleep and suicide prevention. A special focus is the development of rapid-action, low-risk interventions for the prevention of suicide. Our mission is to evaluate transdiagnostic risk factors and biomarkers underlying treatment response that may inform etiology, reduce stigma, and advance innovation. Advocating for its utility as a visible, yet non-stigmatizing warning sign of suicide—our earliest work delineated sleep as a risk factor for suicidal behaviors. Funded by NIH and DOD, we subsequently conducted the first suicide prevention clinical trials, testing efficacy of a rapid-action (6 h) insomnia treatment for suicidal behaviors. These use a mechanisms focus to identify central disease processes (eg, underlying neural circuitry, behavioral factors) for anti-suicidal response. An overarching aim is to harness new technologies to aid risk prediction, precision medicine, and intervention opportunity. We are committed to improving national training practices (e.g., national needs-assessment of medical training parameters; AI for suicide prevention), and lead hospital best practices for safety in screening, triage, and postvention.

    Regarding translation to policy, I have served as a content expert for nationally-directed health initiatives with NIH, VA, DOD, DARPA, SAMHSA, CDC, and The White House. I recently led development of the CA 2020-25 Statewide Strategy for Suicide Prevention, following invited testimony (CA State Assembly) and a commissioned Policy Brief on suicide prevention best practices. Advisory and advocacy work centers on how research guides public health policy and implementation. I am especially committed to initiatives promising impact to suicide prevention on a broad scale, including universal strategies for lethal means restriction and real-time surveillance of suicidal behaviors. To this end, I have been honored to serve as a content expert to The White House Office of Science and Technology for initiatives focused on technology innovation and led advisory work promoting suicide deterrent systems for private organizations and public sites, such as the Golden Gate Bridge. I have consulted for technology companies, as well as private industry and healthcare partners.

    Inspired by maternity leaves coinciding with the above work, I have a separate research line examining organizational development, inclusive practices, sleep and employee wellness. This addresses disparate impact of institutional and federal medical leave practices on recruitment and retention of women. Our program focuses on cost-effective policy for diversity training and reduced attrition of women in medicine, law, STEM and technology fields. As such, I am dedicated to spearheading development of a Stanford Center for Policy, Inclusive Practices, and Equity Education.

    To donate or partner with us, please contact Deborah Stinchfield (Stanford Medical Center Development) medicalgiving@stanford.edu or please contact us directly.

  • Jessica Yelena Breland

    Jessica Yelena Breland

    Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
    Staff, Psych/Public Mental Health & Population Sciences

    BioJessica Breland, MS, PhD is a licensed psychologist and a Core Investigator at the Center for Innovation to Implementation in the VA Palo Alto Health Care System. Dr. Breland received her PhD in psychology from Rutgers and completed her clinical internship at the Baylor College of Medicine in Houston, TX.

    Her work focuses on using quantitative and qualitative methods to: 1) assess outcomes related to the implementation of evidenced-based treatments, especially through controlled trials in novel settings (e.g., primary care) or with novel methods (e.g., apps); 2) identify and reduce racial and ethnic disparities in health; and 3) enhance care for patients with chronic conditions, such as obesity or diabetes.

  • Christiane Brems, PhD, ABPP, ERYT500, C-IAYT

    Christiane Brems, PhD, ABPP, ERYT500, C-IAYT

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioChristiane Brems, PhD, ABPP, RYT-500, C-IAYT, is the Founding Director of YogaX, a Special Initiative in the Department of Psychiatry and Behavioral Science. She received her PhD in Clinical Psychology from Oklahoma State University in 1987. Dr. Brems is licensed as a psychologist in several US states and board-certified as a clinical psychologist by the American Board of Professional Psychology (ABPP). She is a registered yoga teacher (E-RYT500) and certified C-IAYT yoga therapist. She is also certified in Interactive Guided Imagery.

    She began her career in academia at the University of Oklahoma Health Sciences Center. She then served on faculty at the University of Alaska Anchorage for 23 years, where she held a variety of leadership positions, including as (Co-Founding) Director of the Center for Behavioral Health Research and Services, (Co-Founding) Director of the PhD Program in Clinical-Community Psychology, and Interim Vice Provost for Research and Dean of the Graduate School. Most recently, she served for nearly six years as Dean and Professor of the School of Graduate Psychology (SGP) at Pacific University Oregon.

    Dr. Brems has worked for decades as an applied researcher and clinical practitioner with particular interests in health promotion, rural healthcare delivery, and all things yoga. Her work has been funded by grants and contracts from the National Institutes of Health, the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Service Administration, and local and State of Alaska funding sources. She has shared her work extensively in over 120 peer-reviewed journal articles, 100s of technical reports, and several books, including the Comprehensive Guide to Child Psychotherapy (now in its 4th edition), Dealing with Challenges in Psychotherapy and Counseling, Basic Skills in Counseling and Psychotherapy, and others. Dr. Brems is committed to excellence in and integration of clinical services, teaching, consultation, and research.

    Dr. Brems has integrated yoga, mindfulness, complementary interventions, and self-care strategies in her work as a consultant, author, dean, teacher, researcher, mentor, supervisor, colleague, and service provider. She values these practices as crucial aspects of day-to-day professional and personal life and seeks to enhance access to them for all who can benefit.

  • Eve Carlson

    Eve Carlson

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioEve Carlson is a Clinical Professor who focuses on fostering mental health after traumatic stress. She is a clinical psychologist and a researcher with the National Center for Posttraumatic Stress Disorder’s Dissemination and Training Division. Her primary interests are in measurement development and recovery after traumatic stress. She collaborates with faculty in Surgery (David Spain) and Medicine (Lisa Shieh) to study mental health of patients hospitalized after sudden, severe illness or injury, racial/ethnic disparities in traumatic stress risks and responses, screening for risk of mental health problems, and preventive mental health care. As PIs of a multi-center study funded by the National Institute on Minority Health and Health Disparities, Dr. Carlson and Dr. Spain and their collaborators have developed and validated a mental health risk screen for hospital patients admitted after sudden, severe illness or injury. Data from patients who identify as Asian American/Pacific Islander, Black, Latinx, Multiracial, and White were analyzed to select screen items, and the screen accurately predicts later mental health outcomes within these ethnic/racial groups. Our research has also found disparities across ethnic/racial groups in several traumatic stress risk factors and mental health responses. Dr. Carlson is Co-PI with Dr. Shieh of a study funded by Stanford RISE comparing mental health recovery in Latinx and non-Latinx COVID-19 patients to recovery in patients hospitalized with other sudden, severe illness.

  • Steven Chan, MD MBA

    Steven Chan, MD MBA

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psychiatry and Behavioral Sciences

    BioDr. Steven Chan is a Faculty Co-Director at Stanford Frontier Technology Lab, a member of Stanford Psychiatry’s TechHub Leadership Committee, faculty with the Stanford Addiction Medicine Fellowship, and a clinical educator caring for patients with substance use disorders (SUD) and addictions.

    Dr. Chan is a clinical informaticist, addiction medicine physician, and psychiatrist. He is a clinical assistant professor affiliated with the Stanford University School of Medicine, and Chair of the Committee on Innovation at the American Psychiatric Association. Dr. Chan is a sought-after national speaker whose ideas, thoughts, and research have been featured at Google headquarters, JAMA, Telemedicine and e-Health, JMIR (Journal of Medical Internet Research), Wired, PBS, and NPR Ideastream. He serves as Chief Technology Officer and co-founder of AsyncHealth — a University of California-backed digital mental health startup supported by Berkeley SkyDeck PAD-13 — and writes at both @stevenchanMD and @mpowerhacks.

  • Helene Chokron Garneau

    Helene Chokron Garneau

    Sr Res Scholar, Psych/Public Mental Health & Population Sciences

    Current Role at StanfordSenior Research Scientist
    Co-Director, Center for Dissemination and Implementation At Stanford (C-DIAS)

  • Timothy Durazzo

    Timothy Durazzo

    Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Current Research and Scholarly InterestsThe mission of the Durazzo BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, our multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety. Veteran's Administration and Stanford funded Clinical trials are currently being conducted by the BRASS lab that evaluate repetitive transcranial magnetic stimulation techniques as novel complementary treatments to reduce the high rate of relapse experienced by individuals with alcohol and substance abuse disorders. The ultimate goal of our multidisciplinary research program is to promote the development of more effective biomedical and behavioral treatments for alcohol and substance use disorders through consideration of the brain biology, psychology and social circumstances of each individual.

  • David Eagleman

    David Eagleman

    Adjunct Professor, Psych/Public Mental Health & Population Sciences

    BioDavid Eagleman is a neuroscientist, bestselling author, and Guggenheim Fellow. Dr. Eagleman’s areas of research include sensory substitution, time perception, vision, and synesthesia. He also studies the intersection of neuroscience with the legal system, and in that capacity he directs the non-profit Center for Science and Law. Eagleman is the writer and presenter of The Brain, an Emmy-nominated television series on PBS and BBC. He is the author of 8 books, including Livewired, The Runaway Species, The Brain, Incognito, and Wednesday is Indigo Blue. He is also the author of a widely adopted textbook on cognitive neuroscience, Brain and Behavior. His internationally bestselling book of literary fiction, SUM, has been translated into 32 languages, turned into two operas, and named a Best Book of the Year by Barnes and Noble. Dr. Eagleman has been a TED speaker, a guest on the Colbert Report, and profiled in the New Yorker magazine. He has launched several neuroscience companies from his research, including Neosensory and BrainCheck.

  • William O Faustman

    William O Faustman

    Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psychiatry and Behavioral Sciences

    BioDr. Faustman received his doctorate in clinical psychology from the University of Mississippi and completed his internship at the VA Palo Alto Health Care System. He has an active interest in training, administration, forensic practice, and clinical care in inpatient psychiatry. His research interests have focused on severe mental illness with an emphasis in areas such as cognition and clinical assessment.. He serves as a member of the Stanford IRB and coordinates the American Psychological Association accredited postdoctoral fellowship program at the VA Palo Alto. He holds Chartered Psychologist status with the British Psychological Society,

  • Howard H Fenn MD

    Howard H Fenn MD

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences

    BioCurrent CV available on request to
    hhfenn@aol.com

    CLINICAL:
    Inpatient psychiatry attending at VA HCS Palo Alto for over 30 years.
    Medical Director, Geriatric Psychiatry unit, VA HCSC Palo Alto/Menlo Park for 10 years
    Outpatient psychiatrist at Palo Alto Medical foundation/Sutter for 15 years

    CURRENT PUBLICATIONS:
    Lead Editor, Inpatient Geriatric Psychiatry, Springer, 2019

    LEGAL/FORENSIC:
    Consultation practice on legal issues and court testimony for >40 years
    Expert consultant/witness for Coleman vs. California Department of Corrections for 4 years
    Qualified Medical Examiner (QME) for Division of Worker's Compensation for 15 years
    Compensation and Pension Unit, VA HCS Palo Alto for 5 years

    SEMINAR LEADER:
    Psychiatric Issues in Cognitive Impairment -- Stanford/VA Alzheimer's Center (SVAAC)
    Legal Aspects of Geriatric Psychiatry (Stanford/VA Geriatric Psychiatry Fellowship
    Didactic topics on inpatient psychiatry rotation for Stanford Geriatric Psychiatry fellows

    EDUCATIONAL/ADMINISTRATIVE:
    Program Director, Stanford/VA Geriatric Psychiatry Fellowship, 3 years
    Site Director, Inpatient Psychiatry Rotation/Geriatric Medicine Fellowship --6 years

    SCHOLARSHIP:
    Lead Editor of textbook, Inpatient Geriatric Psychiatry, published by Springer in 2019.
    Slide presentations published by the American Society of Clinical Pharmacology (ASCP), editor Ira Glick, MD, entitled:
    --Pharmacological Treatment of PTSD
    --Behavioral and Psychological symptoms of Dementia
    Chapters, review articles on topics of Medication management for Major Neurocognitive Disorder with Behavioral Disturbance
    Chapter in Inpatient Geriatric Psychiatry, in On-Call Geriatric Psychiatry (2016), Springer.
    .

  • Becky Fullmer

    Becky Fullmer

    Administrative Associate 3, Psych/Public Mental Health & Population Sciences

    Current Role at StanfordBecky provides administrative support to Dr. Carolyn Rodriguez and the Rodriguez Lab within the School of Medicine's Psychiatry and Behavioral Sciences Department.

  • Ansgar Furst

    Ansgar Furst

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psych/Public Mental Health & Population Sciences

    BioDr. Furst is a Clinical Associate Professor (affiliated) of Psychiatry and Behavioral Sciences and of Neurology and Neurological Sciences at Stanford University School of Medicine. He is a Principal Investigator and Director of the California War Related Illness and Injury Study Center (WRIISC) Advanced Fellowship Post-Doctoral program and Associate Director of Neuroimaging. He is also a Senior Research Scientist at the Polytrauma System of Care (PSC) at VA Palo Alto Health Care System. Dr. Furst serves as Associate Editor for the journal Frontiers in Neurology and is a member of the editorial board of NEUROLOGY. His research focuses on chronic multisymptom illness, traumatic brain injury, sleep, pain and neurodegenerative diseases.

    For more information please visit:
    https://med.stanford.edu/furstlab.html

    Member of:
    Center for Sleep and Circadian Sciences
    https://med.stanford.edu/cscs.html

    Faculty Affiliate:
    Wu Tsai Human Performance Alliance
    https://humanperformance.stanford.edu

  • Jessica E. Gonzalez

    Jessica E. Gonzalez

    Soc Science Rsch Prof 3, Psych/Public Mental Health & Population Sciences

    BioJessica E. Gonzalez, MSW is the Associate Director for the Mental Health Technology Transfer Center (MHTTC) Network Coordinating Office (NCO). The MHTTC NCO is part of the Center for Dissemination and Implementation (CDI) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. Through the MHTTC School Mental Health Initiative, Jessica is coordinating the work of 12 centers that provide training and technical assistance to the mental health and school mental health workforce to increase the use of evidence-based mental health prevention, treatment, and recovery support services for students across the United States.

    Jessica has worked in the community as a social worker providing mental health services in school and outpatient clinic settings to children and adolescents of diverse socioeconomic, cultural and ethnic backgrounds. In addition, she has over 10 years of experience in project management and coordination for research and evaluation in the areas of early childhood learning and development, special education, post-secondary education attainment, and delivery of school mental health services. Jessica has also worked for several high school and college programs in the area seeking to improve educational outcomes for first-generation and low-income students of color.

  • Cheryl Gore-Felton, Ph.D.

    Cheryl Gore-Felton, Ph.D.

    Walter E. Nichols, MD Professor in the School of Medicine

    Current Research and Scholarly InterestsMy clinical focus is the treatment of anxiety disorders, including post traumatic stress disorder. My research focuses on developing effective psychotherapy interventions to reduce chronic stress as well as enhance positive health behaviors to reduce morbidity and mortality among patients coping with chronic, medical illnesses which are often life threatening.

  • Heather Gotham

    Heather Gotham

    Clinical Associate Professor, Psychiatry and Behavioral Sciences
    Clinical Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsDr. Gotham’s research focuses on implementation science, including factors affecting implementation, and training and education of health care providers, across a range of evidence-based practices for adolescent and adult substance use and mental health disorders, co-occurring mental health and substance use disorders, and screening, brief intervention, and referral to treatment (SBIRT).

  • Laura Michele Hack

    Laura Michele Hack

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Laura Hack is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Director of Novel & Precision Neurotherapeutics at the Stanford Center for Precision Mental Health and Wellness, Director of the Stanford Translational Precision Mental Health Clinic, and Deputy Director of the Precision Neuromodulation Clinic (PNC) within the VA Palo Alto Health Care System. Dr. Hack's translational research program focuses on identifying bioclinical subtypes of depression and testing mechanistically-guided treatments for these subtypes. Dr. Hack studies treatments spanning repurposed medications, such as pramipexole and guanfacine, neuromodulation techniques, ketamine, MDMA, and psilocybin. Clinically, she specializes in delivering novel treatments, including repetitive transcranial magnetic stimulation (rTMS) and ketamine, to patients suffering from treatment-resistant depression and comorbid trauma-related disorders.

  • Haijing Wu Hallenbeck

    Haijing Wu Hallenbeck

    Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psych/Public Mental Health & Population Sciences

    BioHaijing Hallenbeck, PhD, is a research investigator at the National Center for PTSD Dissemination & Training Division at VA Palo Alto Health Care System. She is also an Instructor (Affiliated) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She received her PhD in Clinical Psychology from Washington University in St. Louis and completed her predoctoral clinical internship and postdoctoral research fellowship at VA Palo Alto Health Care System. Funded by the VA VISN 21 Early Career Award Program, Dr. Hallenbeck's research focuses on PTSD and depression and their impact on psychosocial functioning. She studies how to leverage digital health technology (e.g., mobile apps) and analytic tools (e.g., machine learning) to provide timely and personalized assessments and interventions for these conditions.

    Email: haijing.hallenbeck@stanford.edu

  • Kate Hardy

    Kate Hardy

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.

  • Alesha Heath

    Alesha Heath

    Basic Life Res Scientist, Psych/Public Mental Health & Population Sciences

    BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.

    Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease.

  • Keith Humphreys

    Keith Humphreys

    Esther Ting Memorial Professor

    Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.

  • Shaili Jain, MD

    Shaili Jain, MD

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Jain serves as a psychiatrist at the VA Palo Alto Health Care System. She is board certified in general psychiatry, with specialty expertise in posttraumatic stress disorder (PTSD), primary and mental health integrated care, and women’s health psychiatry. She is a health services researcher, affiliated with the National Center for PTSD, who focuses on developing innovative ways to enhance the reach of mental healthcare in underserved populations with PTSD. Her work is widely accredited for elucidating the role of paraprofessionals and peers in the treatment of American veterans with PTSD.

    Dr. Jain is an internationally recognized leader in communicating to the public about trauma and PTSD. Her posts for her Psychology Today blog on PTSD, In the Aftermath of Trauma, have been viewed over 250,000 times. Her acclaimed debut non-fiction trade book, The Unspeakable Mind: Stories of Trauma and Healing from the Frontlines of PTSD Science (Harper, 2019), was nominated for a National Book Award, and her essays and commentaries on trauma and PTSD have been presented by the BBC, CNN, The New York Times, STAT, Newsweek, The Los Angeles Times, TEDx, public radio, and others